Sofgen Pharma S.A.

• Accepted (ET)
• Dec 56-K—
  Foreign company update0001213900-25-118714 · 375.8 KB
  SEC(opens sec.gov)
• Nov 196-K—
  Foreign company update0001213900-25-112342 · 6.1 MB
  SEC(opens sec.gov)
• Aug 16-K—
  Foreign company update0001213900-25-070719 · 13.9 KB
  SEC(opens sec.gov)
• Jul 146-K—
  Foreign company update0001213900-25-063804 · 28.7 KB
  SEC(opens sec.gov)
• May 136-K—
  Foreign company update0001213900-25-042301 · 16.4 KB
  SEC(opens sec.gov)
• Apr 146-K—
  Foreign company update0001213900-25-031270 · 3.2 MB
  SEC(opens sec.gov)
• Apr 96-K—
  Foreign company update0001213900-25-030333 · 61.2 KB
  SEC(opens sec.gov)
• Mar 256-K—
  Foreign company update0001013762-25-002205 · 334.3 KB
  SEC(opens sec.gov)
• Mar 66-K—
  Foreign company update0001213900-25-020912 · 2.8 MB
  SEC(opens sec.gov)
• Feb 196-K—
  Foreign company update0001213900-25-015065 · 4.0 MB
  SEC(opens sec.gov)

• Bernal Jaramillo Daniel AugustoDirector
• Deseja Trust10% Owner
• Eguiguren AlbertoDirector
• Garcia Iragorri CarlosDirector
• Hoche Partners Pharma Holding S.A.10% Owner
• Manieu Alexandre WeinsteinDirector, 10% Owner
• Minski JoseDirector, 10% Owner
• Minski RubenDirector, Chief Executive Officer, 10% Owner
• Moreira Muniz Fernando SebastianDirector, 10% Owner
• Palacios Luis AlbertoChief Commercial Officer

No tickers on record.

• business

  9 RUE DE BITBOURG

  LUXEMBOURG

• mailing

  9 RUE DE BITBOURG

  LUXEMBOURG

• Procaps Group, S.A.2025-11-19